Case studies in acute care
| GEHC-GSS-TTOD-NU4304 | |
| Clinical Training | |
| GE HealthCare | |
Add to Wish List
Login To Shop
Please select date
Second Opinion Approval Needed
Enter your approval number and submit to add item(s) to cart.
Approval Number
Please enter approval number
OR
Don't know your approval number? Call 800-437-1171
Enter opt 1 for the first three prompts, and have your System ID available.
If you add item(s) to cart and submit your order without the
approval number, GE will contact you before your order
can be confirmed for shipment.
Second Opinion Approval Needed
Select your approver's name and submit to add item(s) to your cart
Approver Name
Please Select Approver Name
OR
Don't know your approval number? Call 800-437-1171
Enter opt 1 for the first three prompts, and have your System ID available.
If you add item(s) to cart and submit your order without
selecting an approver, GE will contact you before your order
can be confirmed for shipment.
Product Overview
In 2010, the American Association of Critical-Care Nurses (AACN) endorsed the scientific statement from both the American Heart Association (AHA) and American College of Cardiology (ACC) entitled "Prevention of Torsades de Pointes (TdP) in Hospital Settings," acknowledging that this silent conduction abnormality can lead to sudden cardiac arrest. In patients who suffer an out-of-hospital cardiac arrest and remain comatose, the AHA and ACC recommend implementation of therapeutic hypothermia in an effort to preserve neurological function. By the end of this program, the participant should be able to: 1. Describe the clinical significance of the QT and QTc interval on an electrocardiogram (ECG). 2. List three commonly used medications that can prolong the QT/QTc interval. 3. Identify patients who are suitable candidates for therapeutic hypothermia. 4. State three important aspects of nursing management for the patient with DKA. 5. Describe the acceptable timeframe for safely lowering high blood glucose levels. 6. Identify clinical signs of hypoglycemia. 7. Discuss three potential dangers of long-acting insulin.
